Metraipolis › archive › dc_6e73eec5562f

Biomedical Technologies for Androgenic Alopecia Treatment: Advance, Mechanism and Future Direction — Europe PMC PMID:42266490

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42266490
DOI
10.34133/research.1312
License (as archived)
solo-consultazione
Archived
2026-10-31T16:44:15.540Z
SHA-256 of the archived text
6f0a5f49ca9dfeb051c08189af173bf5300fe4ba0be9962af63357be762efb14
Stable URL of this page
https://metraipolis.com/documento/dc_6e73eec5562f

How to cite

Biomedical Technologies for Androgenic Alopecia Treatment: Advance, Mechanism and Future Direction — Europe PMC PMID:42266490 — Europe PMC (en), https://europepmc.org/article/MED/42266490 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6e73eec5562f (Metraipolis archive dc_6e73eec5562f, sha256 6f0a5f49ca9dfeb051c08189af173bf5300fe4ba0be9962af63357be762efb14)
BibTeX
@misc{dc6e73eec5562f,
  title = {Biomedical Technologies for Androgenic Alopecia Treatment: Advance, Mechanism and Future Direction — Europe PMC PMID:42266490},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42266490},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6e73eec5562f; sha256 6f0a5f49ca9dfeb051c08189af173bf5300fe4ba0be9962af63357be762efb14},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42266490. Agents can read the archived copy with the MCP tool read_document.